Stanford University: Alzheimer Disease trials
The registry lists 10 Alzheimer Disease studies with Stanford University as lead sponsor. 2 are open to participants now and 4 have results posted.
Phase 2 2Phase 3 1No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Vagus Nerve Stimulation to Enhance Memory in AgingNot yet recruitingNCT07214194Not applicable
- Bumetanide in Patients With Alzheimer's DiseaseRecruitingNCT06052163Phase 2
- Magnesium L-Threonate for the Enhancement of Learning and Memory in People With DementiaCompletedNCT02210286Not applicableResults posted
- Light Treatment for Sleep/Wake Disturbances in Alzheimer's DiseaseCompletedNCT00946530Not applicableResults posted
- Raloxifene for Women With Alzheimer's DiseaseCompletedNCT00368459Phase 2Results posted
- The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease PatientsCompletedNCT00255086Phase 3Results posted
- Assessing Cognitive Decline at HomeActive, not recruitingNCT06704971
- An Objective Assessment Tool for Evaluating Functioning in Older AdultsActive, not recruitingNCT06489847
- Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's DementiaActive, not recruitingNCT04100057Not applicable
- The PLasma for Alzheimer SymptoM Amelioration (PLASMA) StudyCompletedNCT02256306Not applicable